Study of Injection Sugammadex after muscle relaxation agents in Cardiac Catheterisation Laboratory
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: Q20-Q28- Congenital malformations of the circulatory systemHealth Condition 2: I00-I99- Diseases of the circulatory system
- Registration Number
- CTRI/2023/06/053360
- Lead Sponsor
- Institutional Research Society
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA grade I-IV patients.
2. Age between 20 and 60 years.
3. Patients posted for elective cardiac catheterisation procedures in the cathlab.
4. Availability of informed consent and willingness of the patient to be a part of the study.
Exclusion Criteria
1. Patients requiring emergency surgery.
2. Incapacity to consent
3. Patient with renal, hepatic and pre-existing pulmonary comorbidities.
4. Patients allergic to Sugammadex, neostigmine or glycopyrrolate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method